News Releases
April 22, 2009
An herb recently found to kill pancreatic cancer cells also appears to inhibit development of pancreatic cancer as a result of its anti-inflammatory properties, according to researchers from the Kimmel Cancer Center at Jefferson. The data were presented at the AACR 100th Annual Meeting 2009 in Denver. (Abstract #494)
April 22, 2009
Hypofractionated stereotactic radiotherapy was well-tolerated and improved symptoms in patients with recurrent low-grade glioma, according to researchers from the Kimmel Cancer Center at Jefferson. The data were presented at the AACR 100th Annual Meeting 2009. (Abstract #3617)
April 22, 2009
When given with vitamin K, the necessary sorafenib dose was lower, which could help curb a debilitating adverse effect. A combination of sorafenib and vitamin K had an effect in vitro on both human pancreas cancer and hepatocellular carcinoma, according to researchers from the Kimmel Cancer Center at Jefferson. Data from the two studies were presented at the AACR 100th Annual Meeting 2009 in Denver. (Abstract #5470 and #5483)
April 17, 2009
David J. Kupfer, M.D., Thomas Detre Professor and Chair, Department of Psychiatry, University of Pittsburgh School of Medicine, and director of Research at the Western Psychiatric Institute and Clinic, will present “The Medical Burden of Bipolar Disorder”at the 2009 Albert M. Biele, M.D. Memorial Lecture, sponsored by the Department of Psychiatry and Human Behavior at Thomas Jefferson University. The 31st annual Biele Lecture will be held Wednesday, April 29, 2009 at 11 A.M., in the DePalma Auditorium.
April 16, 2009
A protein called Mcl-1 plays a critical role in melanoma cell resistance to a form of apoptosis called anoikis, according to research published this week in Molecular Cancer Research.
April 15, 2009
Autophagy, a process that helps leukemia cells evade cell death, appears to be an effect of imatinib treatment. The therapeutic effects of the blockbuster leukemia drug imatinib may be enhanced when given along with a drug that inhibits a cell process called autophagy, researchers from the Kimmel Cancer Center at Jefferson reported in the Journal of Clinical Investigation.
April 15, 2009
Thomas Jefferson University and Hospital will be home to more leading-edge molecular research, thanks to an alliance with Roche Diagnostics.
April 15, 2009
Researchers from the Kimmel Cancer Center at Jefferson were awarded a Susan G. Komen for the Cure Promise Grant of almost $6.7 million for five years for continued breast cancer research.
April 14, 2009
Thomas Jefferson University Hospital, Center City Campus, ranked as one of America’s best hospitals, has been granted MAGNET® recognition for nursing excellence from the American Nurses Credentialing Center’s (ANCC) MAGNET Recognition Program®. ANCC is a subsidiary of the American Nurses Association.